Clinical Trial Update: Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update examining potential drug–drug interactions between RAY1225 and Warfarin, Atorvastatin, Metformin, and Digoxin in individuals wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DIGOXIN (Digoxin)
• RAY1225
• Warfarin (warfarin)
• atorvastatin (atorvastatin)
• metformin (metformin)

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING